Panteleimon D. Mavroudis

机构：Sanofi (France), Sanofi (United States) · ORCID：0000-0002-0512-4147

发表论文 43 篇 · 总被引 771 次 · h-index 16

代表论文

• Machine Learning guided early drug discovery of small molecules (2022 · Drug Discovery Today · 被引 75)
• Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in Humans (2025 · Journal of Medicinal Chemistry · 被引 27)
• Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group Survey (2022 · The AAPS Journal · 被引 27)
• Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure (2024 · Clinical and Translational Science · 被引 23)
• Application of machine learning in combination with mechanistic modeling to predict plasma exposure of small molecules (2023 · Frontiers in Systems Biology · 被引 22)
• A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokinetics (2024 · Journal of Pharmacokinetics and Pharmacodynamics · 被引 12)